Home peritoneal ultrafiltration in patients with severe congestive heart failure without end-stage renal disease.
Congestive heart failure (CHF), mainly because of ischemic heart disease, is becoming a common medical problem. As CHF worsens and reaches New York Heart Association (NYHA) class IV, many patients can become refractory to medical therapy, especially those who are elderly or who have pre-existing non uremic chronic renal failure. For such patients, quality of life, morbidity, and mortality are expected to be bad. Our objective in the present study was to make a preliminary assessment of the usefulness of icodextrin administered in a single nocturnal peritoneal exchange to patients nonrespondent to the maximal conventional medical therapy. We studied two patients (aged 80 and 87 years), who were affected by severe dilatative cardiomyopathy and moderate-to-severe chronic renal failure. After at least 12 months of treatment, we observed a significant improvement in quality of life and a reduction in morbidity and hospitalization in both patients. Both patients also significantly increased their creatinine clearance. One patient maintained ejection fraction stability (22%-->27%); the other experienced an increase in ejection fraction to 50%from 25%. These preliminary observations suggest that a single nocturnal exchange with icodextrin can be an effective treatment in patients affected by refractory CHF and moderate-to-severe chronic renal failure.
Bertoli
Silvio V
SV
Renal Unit, Policlinico MultiMedica, Sesto San Giovanni, Milan, Italy. silvio.bertoli@multimedica.it
Ciurlino
Daniele
D
Maccario
Massimo
M
Martino
Stefania
S
Bigatti
Giada
G
Traversi
Lara
L
Procaccio
Mirella
M
Buzzi
Laura
L